Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Clay

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Gynecologie, Obstetrique & Fertilite|August 19, 2007
[Fifteen practical questions concerning gestational diabetes]J-C Clay, P Deruelle, C Fischer, et al.
The British Journal of Venereal Diseases|October 1, 1983
Efficacy of vaccine Ac NFU1 (S-) MRC 5 given after an initial clinical episode in the prevention of herpes genitalisC B Woodman, A Buchan, A Fuller, et al.
The British Journal of Venereal Diseases|December 1, 1982
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalisG R Skinner, C B Woodman, C E Hartley, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Gynecologie, Obstetrique & Fertilite|August 19, 2007
[Fifteen practical questions concerning gestational diabetes]J-C Clay, P Deruelle, C Fischer, et al.
The British Journal of Venereal Diseases|October 1, 1983
Efficacy of vaccine Ac NFU1 (S-) MRC 5 given after an initial clinical episode in the prevention of herpes genitalisC B Woodman, A Buchan, A Fuller, et al.
The British Journal of Venereal Diseases|December 1, 1982
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalisG R Skinner, C B Woodman, C E Hartley, et al.
Pageof 4